Long‐term entecavir or tenofovir disoproxil fumarate therapy in treatment‐naïve chronic hepatitis B patients in the real‐world setting

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 5, 2015-05 ,pp. : 504-510

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sublingual immunotherapy provides long‐term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real‐world database analysis

By  

ALLERGY, Vol. 73, Iss. 1, 2018-01 ,pp. : 165-177

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real-world use patterns of olanzapine long-acting injection in the United States: comparison to the recommended dosing strategy

By Case Michael G.   Karagianis Jamie L.   Schuh Kory J.   Hoffmann Vicki Poole  

Current Medical Research and Opinion, Vol. 29, Iss. 11, 2013-11 ,pp. : 1533-1537

Informa Healthcare

Access to resources Recommend Favorite

Reducing the Use of H2‐Receptor Antagonists in the Long‐Term‐Care Setting

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 40, Iss. 4, 1992-04 ,pp. : 359-364

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting

By Bergenstal Richard M.   Garrison Louis P.   Wintle Matthew   Blickensderfer Amy   Wade Rolin   Hou Likun   Miller Lesley-Ann   Scism-Bacon Jamie   Zagar Anthony   Misurski Derek   Herman William H.  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 531-540

Informa Healthcare

Access to resources Recommend Favorite